目的:探究对特发性血小板减少性紫癜患者实施地塞米松与甲基强的松龙的治疗对患者T细胞亚群的影响.方法:本研究在我院进行治疗的特发性血小板减少性紫癜的患者进行随机的抽查,采用随机数字表法将260例患者分为地塞米松组和甲基强的松龙组两组,每组各130例,比较治疗前后的相关指标.结果:两组患者的治疗均对CD4+、CD8+和CD4+/CD8+水平有影响,且均可对炎性因子产生影响,两组间治疗后也存在显著差异,且与观察组相比有显著差异(P＜0.05).结论:给予患有特发性血小板减少性紫癜患者地塞米松和甲基强的松龙的治疗“,”Objective:To explore the effect of dexamethasone and methylprednisolone treatment on patients with idiopathic thrombocytopenic purpura on T cell subsets. Methods:In this study, patients with idiopathic thrombocytopenic purpura treated in our hospital were randomly selected. Using a random number table method, 260 patients were divided into two groups:dexamethasone group and methylprednisolone group. There were 130 cases in each group, and the relevant indexes before and after treatment were compared. Results:The treatment of the two groups of patients had an impact on the levels of CD4+, CD8+ and CD4+/CD8+, and both had an impact on inflammatory factors. There were also significant differences between the two groups after treatment, and there were significant differences compared with the observation group (P＜0.05). Conclusion:The treatment of patients with idiopathic thrombocytopenic purpura with dexamethasone and methylprednisolone has a significant clinical impact on the patient\'\'s T cell subsets, and the Th1/Th2 ratio tends to be normal to achieve treatment The effect of idiopathic thrombocytopenic purpura can be used clinically.